Osaic Holdings
NGEN

Osaic Holdings’s NervGen Pharma NGEN Stock Holding History

Osaic Holdings’s Portfolio NGEN Stock Details NGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Buy
51,093
+11,102
+28% +$34.5K ﹤0.01% 4903
2026
Q1 		$151K Buy
+39,991
New +$173K ﹤0.01% 4374

Other funds holding NGEN

EAM
Empery Asset Management New York $86.5M AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $5.1B AUM 39.13% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Osaic Holdings's NGEN Position: Q2 2026 in Review

Osaic Holdings increased its NervGen Pharma (NGEN) stake by 28% in Q2 2026, buying an estimated $34.5K and bringing the position to 51,093 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #4903.

Osaic Holdings first reported a position in NGEN in Q1 2026 and has held it in 2 quarters since. The position peaked at $151K in Q1 2026. 62 funds tracked by Wall St. Rank hold NGEN as of Q2 2026.

  • Osaic Holdings held 51,093 shares of NervGen Pharma worth $105K as of Q2 2026.
  • Osaic Holdings bought 11,102 NervGen Pharma shares in Q2 2026, an estimated $34.5K.
  • NervGen Pharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4903 holding.
  • Osaic Holdings first reported a position in NervGen Pharma in Q1 2026 and has held it in 2 quarters since.
  • Osaic Holdings's NervGen Pharma position peaked at $151K in Q1 2026.
  • 62 funds tracked by Wall St. Rank held NervGen Pharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.